Pharmocann Global Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
PMCN
IL0010968902
Healthcare Facilities & Services
Sales 2022 | 22.66M 5.96M | Sales 2023 | 14.41M 3.79M | Capitalization | 3.12M 821K |
---|---|---|---|---|---|
Net income 2022 | -25M -6.58M | Net income 2023 | -9M -2.37M | EV / Sales 2022 | 0.4 x |
Net cash position 2022 | 925K 243K | Net cash position 2023 | 768K 202K | EV / Sales 2023 | 0.16 x |
P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 19-06-16 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-12-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 22-12-04 |
Locar Gila
BRD | Director/Board Member | 51 | 22-11-28 |
Director/Board Member | 43 | 22-11-28 |
1st Jan change | Capi. | |
---|---|---|
+30.93% | 272M | |
+34.57% | 269M | |
+49.42% | 200M | |
+40.00% | 134M | |
-40.31% | 124M | |
-28.57% | 121M | |
+115.91% | 120M | |
+150.00% | 75.33M | |
-23.08% | 66.62M |